Heparin from Intestine and Lung Source Administered in Large Dose to Dogs with Acute Myocardial Ischemia

Summary

Intestinal mucosa heparin (IMH) and beef lung heparin (BLH) were infused into dogs subjected to myocardial ischemia by intermittent coronary artery occlusions. The IMH was from a mixture of beef, sheep, and pig intestinal mucosa. Initial control occlusion and recovery was followed by a second occlusion with 60,000 units of IMH or BLH added. Electrocardiographic S-T segment elevations (ST) were measured acutely. There were no significant differences in ST in non-ischemic myocardium before occlusions or with occlusions. In ischemic myocardium, IMH significantly lowered control ST 84% in amount (t = 6.1 p <0.00005), and 76% in number (t = 11.6 p <0.00001). BLH lowered control ST a significant, lesser, 36% in amount (t = 3.6 p <0.008), and 35% in number (t = 3.2 p <0.01). The difference between IMH and BLH in ischemic myocardium was a significant 48% in amount (t = 4.0 p <0.0007), and 41% in number (t = 2.0 p <0.06). Myocardial adenosine triphosphate (ATP) levels were assayed after 90 min. ATP levels were 31% higher in both ischemic and non-ischemic myocardium in IMH-treated dogs than in BLH- treated. It was concluded that IMH and BLH are functionally different, and IMH was significantly more effective.

• References

• 1 Amann R, Werle E. 1956; Ober Komplexe von Heparin mit Histamin und anderen di- und polyamine. Klinische Wochenschrift 34: 207
• 2 Bates BJ, Diamond S, D’Agnostino BS. 1973; Comparison of anticoagulant activity of two preparations of purified heparin. Clinical Pharmacology and Therapeutics 14: 287
• 3 Carleton RA, Sanders CA, Burack WR. 1960; Heparin administered after acute myocardial infarction. New England Journal Medicine 263: 1002
• 4 Drapkin A, Merskey C. 1972; Anticoagulant therapy after acute myocardial infarction. Journal American Medical Association 222: 541
• 5 Gillet MP T, Besterman EM M. 1973; Effects of heparin derived from different tissues on plasma-phospholipids and platelet aggregation. Lancet 2: 1204
• 6 Gillford RH, Feinstein AR. 1969; A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. New England Journal Medicine 280: 351
• 7 Gomez-Perez F. 1972; Anticoagulant activity of two commercially available heparin preparations. A controlled study Journal Clinical Pharmacology 12 (10) 413
• 8 Holten C, Lundsteen E. 1942; The use of heparin in coronary thrombosis. Nordisk Medicine 13: 13
• 9 Jacques LB, Ballieux RE, Van Arkel C. 1963; Microelectrophoresis of heparin. Acta medica Scandinavica 174: 717
• 10 Kociba GJ. 1977. Disseminated intravascular coagulation. In: KIRK RW. (Ed.) Current Veterinary Therapy. 6. Ed Saunders Company; Philadelphia: p 448
• 11 Levine WG. 1970. Heparin and oral anticoagulants. In: Goodman LS, Gilman A. (Ed.) The Pharmacological Basis of Therapeutics. 4. Ed MacMillan Company; New York: p 1450
• 12 Manson DL, Fullerton HW. 1956; Anticoagulant therapy in cardiac infarction. British Medical Journal 1: 6
• 13 Novak E, Sekhar NC, Dunham NW. 1972; A comparative study of the effects of lung and gut heparin on platelet aggregation and protamine neutralization in man. Clinical Medicine 19 (07) 22
• 14 Saliba Jr MJ, Griner LA. 1970; Heparin efficacy in bums. I. significant early modification of experimental third-degree guinea pig thermal burns and ancillary findings. Aerospace Medicine 41: 179
• 15 Saliba Jr MJ, Dempsey WC, Kruggel JL. 1973; Large burns in humans; treatment with heparin. Journal American Medical Association 225: 261
• 16 Saliba Jr MJ, Saliba RJ. 1975; Heparin in burns: Dose related and dose depent effects. Thrombosis et Diathesis Haemorrhagica 33: 113
• 17 Saliba Jr MJ, Covell JW, Bloor CM. 1976; a Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog. American Journal of Cardiology 37: 599
• 18 Saliba Jr MJ, Kuzman WJ, Marsh DG. 1976; b Effects of heparin in anticoagulant doses on the electrocardiogramm and cardiac enzymes in patients with acute myocardial infarction. American Journal of Cardiology 37: 605
• 19 Seliger HH, Mcelroy WD. 1965. In: Seliger HH, Mcelroy WD. (Ed.) White, Physical And Biological Action. Academic Press; New York: p 367
• 20 Schumacher Jr EE, Drake JR, Feenstra LH. 1962; Heparin and oral anticoagulants: comparison with special reference to acute myocardial infarction. American Journal of Cardiology 9: 568
• 21 Solandt DY, Best CH. 1938; Heparin and coronary thrombosis in experimental animals. Lancet 2: 130
• 22 Solandt DY, Nassim R, Best CH. 1939; Production and prevention of cardiac mural thrombosis in dogs. Lancet 2: 592
• 23 Walton PL, Ricketts CR, Bangham DR. 1966; Heterogeneity of heparin. British Journal of Haematology 12: 310